VBL Therapeutics Announces Third Quarter 2019 Financial Results

Ads

You May Also Like

ThromboGenics Business Update – Q3 2017

Press release                                                          20 October, 2017Regulated Information Diabetic Eye Disease programs progressing €53.7 million cash ...